M. Stanley Whittingham : Pioneer on Rechargeable Lithium Battery

-


 M. Stanley Whittingham is a well-known scientist and researcher who has made significant contributions to the creation of lithium-ion batteries. He was born in the United Kingdom on December 22, 1941.

Whittingham's seminal work on rechargeable lithium batteries began in the 1970s, while he was employed with Exxon Research and Engineering Company. His study concentrated on developing a high-energy-density battery that could effectively store and discharge electrical energy. Whittingham's research resulted in the discovery of intercalation, a technique that allows lithium ions to be introduced and withdrawn from the atomic layers of specific materials. This breakthrough paved the way for the creation of lithium-ion batteries.


Whittingham was awarded the Nobel Prize in Chemistry in 2019 along with John B. Goodenough and Akira Yoshino in appreciation of his pioneering achievements. The Nobel Committee recognized their efforts in developing lithium-ion batteries, which have revolutionized portable electronic gadgets and are widely employed in a variety of applications, including electric cars and grid energy storage.

Professor Whittingham has made important contributions to the field of energy storage since his revolutionary study. He is a prominent professor of chemistry and materials science at the State University of New York's Binghamton University, where he continues to conduct research and train young scientists and engineers. Whittingham's work has had a significant influence on the development of clean and sustainable energy technology, establishing him as a pioneer.

Comments

Post a Comment

Popular posts from this blog

War of the Currents: The Rivality between Edison Vs Tesla

-
Image
 The "War of the Currents" was a time in history in the late nineteenth century when there was fierce competition between two competing electrical power systems: Thomas Edison's direct current (DC) system and Nikola Tesla and George Westinghouse's alternating current (AC) system. Thomas Edison pioneered the use of direct current (DC) electricity for electrical distribution through his firm Edison Electric Light firm (later known as General Electric or GE). Due to its restricted transmission capabilities, DC electricity travels in just one way and necessitates power plants being situated near customers. On the other side, Nikola Tesla, with the financial backing of George Westinghouse, lobbied for alternating current power. AC electricity allows for more efficient long-distance transmission and the use of transformers to step up or step down voltage levels as needed. As each side sought to control the burgeoning electric power business, tensions between these two syste
Read more

Henry Bragg & Lawrence Bragg : The Only Father Son duo who won the Noble Prize in Physics

-
Image
  Sir William Henry Bragg (1862-1942)       Born at Wigton, Cumberland, England, on July 2, 1862.    Studied  At King's College, Cambridge, he studied mathematics and physics.     Pioneered research in the field of X-ray crystallography.     Developed the concept of X-ray diffraction with his son Lawrence Bragg.     Proposed Bragg's law, which explains X-ray diffraction by crystals and allows crystal shapes to be determined.     The structure of numerous crystals, including minerals and chemical molecules, was investigated.     X-ray crystallography was used to investigate the molecular structures of key compounds such as proteins.     He was a professor at the Universities of Leeds (1909-1915) and Manchester (1915-1919).     In 1915, he and his son Lawrence shared the Nobel Prize in Physics for their work on X-ray crystallography.
Read more

Big Pharma Conspiracy

-
Image
 The term "Big Pharma conspiracy" refers to the widespread idea that pharmaceutical firms engage in clandestine and immoral practices in order to maximize profits at the expense of public health. While it is true that the pharmaceutical business is profit-driven, valid concerns regarding corporate practices must be distinguished from unsubstantiated conspiracy theories. Consider the following crucial points:     Research & Development: Creating new pharmaceuticals is a time-consuming and expensive process that requires considerable research, clinical trials, and regulatory clearance. Pharmaceutical businesses devote enormous amounts to research and development (R&D) in order to identify and commercialize new medications. While profit is a motivator, it is also vital to recuperate the significant expenditures of R&D and to support future innovation. Patent protection is obtained by pharmaceutical corporations in order to preserve their investments in medication d
Read more